Vivos Therapeutics Ratios (2019-2025) | VVOS

Ratios Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
Gross Margin 75.58%83.34%78.45%81.30%78.02%80.59%70.02%70.71%70.01%61.85%58.78%60.35%60.59%61.80%52.92%64.32%56.65%65.39%60.47%56.71%50.03%55.24%58.04%
EBT Margin -81.38%-43.88%-55.72%-189.46%-98.58%-89.90%-119.95%-168.68%-146.30%-167.11%-127.98%-154.15%-44.15%-162.83%-63.41%-132.45%-110.06%-47.61%-67.77%-78.02%-128.12%-131.23%-79.61%
EBIT Margin -80.02%-43.33%-55.21%-188.94%-98.78%-90.30%-121.05%-168.66%-182.19%-166.44%-127.34%-153.49%-129.76%-133.05%-110.27%-127.25%-110.70%-47.76%-68.52%-75.88%-129.91%-127.36%-69.79%
EBITDA Margin -77.63%-41.01%-50.28%-189.37%-95.88%-88.51%-118.85%-166.39%-176.70%-161.66%-122.63%-145.90%-124.58%-130.10%-107.24%-121.09%-107.78%-45.29%-65.93%-70.47%-123.28%-119.50%-63.90%
Operating Margin -80.02%-43.33%-55.21%-188.94%-98.78%-90.30%-121.05%-168.66%-182.19%-166.44%-127.34%-153.49%-129.76%-133.05%-110.27%-127.25%-110.70%-47.76%-68.52%-75.88%-129.91%-127.36%-69.79%
Net Margin -88.55%-50.86%-62.68%-345.68%-98.58%-89.90%-119.95%-168.25%-146.30%-167.11%-127.98%-154.15%-44.15%-162.83%-63.41%-132.45%-110.06%-47.61%-67.77%-78.02%-128.12%-131.23%-79.61%
FCF Margin -13.83%-29.30%-20.85%-112.89%-120.71%-111.43%-97.98%-102.50%-170.69%-123.06%-140.25%-81.01%-97.95%-91.49%-89.49%-89.62%-78.01%-77.55%-113.78%-82.88%-130.04%-111.81%-60.70%
Efficiency
Assets Average 23.64M34.06M43.59M37.36M31.62M26.97M21.39M16.06M15.41M15.42M12.03M10.52M11.27M13.82M15.59M15.32M13.28M18.66M25.84M
Equity Average 15.63M25.41M34.47M29.00M23.29M17.94M12.35M7.33M5.90M4.55M1.08M0.23M0.50M3.46M7.01M7.81M6.18M4.50M3.56M
Invested Capital 0.77M18.21M15.50M37.74M33.73M26.80M21.04M14.84M9.86M4.80M6.99M2.11M0.05M0.41M0.58M6.35M7.67M7.95M4.41M4.74M2.87M
Asset Utilization Ratio 0.560.430.360.450.540.620.771.001.051.001.211.311.191.010.940.981.100.770.67
Leverage & Solvency
Interest Coverage Ratio -58.50-78.45-106.95-362.86-0.00M-0.00M-611.44-0.00M-174.71-188.22-150.19-2.02-2.30
Debt to Equity -1.260.080.090.030.040.051.733.44
Debt Ratio 0.490.050.060.030.030.040.300.34
Equity Ratio -0.390.670.650.790.790.760.710.610.540.350.410.150.000.040.050.400.500.520.390.180.10
Times Interest Earned -58.50-78.45-106.95-362.86-0.00M-0.00M-611.44-0.00M-174.71-188.22-150.19-2.02-2.30
Valuation
Enterprise Value -0.47M-18.21M-14.10M-34.20M-28.50M-24.03M-17.83M-12.70M-6.72M-3.52M-7.05M-3.94M-1.00M-1.64M-2.61M-6.90M-6.31M-6.26M-2.34M-4.40M-3.10M
Return Ratios
Return on Sales -0.81%-0.44%-0.56%-1.89%-0.99%-0.90%-1.20%-1.69%-1.46%-1.67%-1.28%-1.54%-0.44%-1.63%-0.63%-1.32%-1.10%-0.48%-0.68%-0.78%-1.28%-1.31%-0.80%
Return on Capital Employed -0.79%-0.63%-0.54%-0.68%-0.93%-1.31%-1.71%-2.71%-3.15%-3.01%-3.95%-5.35%-5.03%-1.88%-1.19%-1.08%-1.32%-1.16%-0.89%
Return on Assets -0.55%-0.46%-0.44%-0.54%-0.70%-0.93%-1.18%-1.48%-1.31%-1.22%-1.28%-1.29%-1.39%-0.87%-0.81%-0.73%-0.85%-0.77%-0.66%
Return on Equity -0.83%-0.61%-0.56%-0.70%-0.95%-1.40%-2.04%-3.25%-3.43%-4.12%-14.32%-59.63%-31.59%-3.49%-1.80%-1.43%-1.83%-3.20%-4.82%